EnerplatTM (Eltrombopag) 50mg

Introduction to Promacta (Eltrombopag) 50mg 

EnerplatTM (Eltrombopag) 50mg is a prescription medicine used to treat certain blood disorders associated with low platelet counts. It belongs to a class of medicines known as thrombopoietin receptor agonists, which help increase platelet production in the body.

EnerplatTM (Eltrombopag) 50mg is classified under Prescription Medicines, Hematology Drugs, Platelet-Stimulating Agents, and Oral Therapies. It contains Eltrombopag, which works by stimulating the bone marrow to produce more platelets, reducing the risk of bleeding.

In some markets, EnerplatTM 50mg is available as a generic version of Eltrombopag, offering similar therapeutic benefits when prescribed by a qualified healthcare professional.

What Is Promacta (Eltrombopag)? 

Promacta is the original brand name for Eltrombopag, an oral medication used to manage low platelet counts in various medical conditions.

Eltrombopag belongs to a group of medicines called thrombopoietin receptor agonists. These drugs help increase platelet production by stimulating specific receptors in the bone marrow.

Generic versions such as EnerplatTM 50mg contain the same active ingredient and may be used depending on physician recommendation and availability.

Drug Class and Mechanism of Action 

Eltrombopag is classified as a thrombopoietin receptor agonist with hematopoietic properties.

How Eltrombopag Works 

It works in several ways:

• Stimulates platelet production in the bone marrow
• Activates thrombopoietin (TPO) receptors
• Helps maintain adequate platelet levels to reduce bleeding risk

Through these mechanisms, Eltrombopag helps manage conditions associated with low platelet counts.

How Promacta Works in the Body 

Eltrombopag acts on bone marrow cells to increase platelet production, helping restore normal platelet levels.

Key Actions of Eltrombopag 

• Increases platelet count
• Reduces risk of bleeding episodes
• Supports normal blood clotting function

Generic versions like EnerplatTM provide similar therapeutic benefits when used appropriately.

Medical Uses of Promacta (Eltrombopag) 50mg 

EnerplatTM 50mg is prescribed for several hematologic conditions.

Eltrombopag for Chronic Immune Thrombocytopenia (ITP) 

It is commonly used in patients with chronic ITP who have not responded well to other treatments.

Potential Benefits 

• Increased platelet count
• Reduced bleeding risk
• Improved quality of life

Eltrombopag for Aplastic Anemia 

Eltrombopag may be used in severe aplastic anemia cases.

Treatment Benefits 

• Improves blood cell production
• Reduces transfusion dependency
• Supports bone marrow function

Eltrombopag for Hepatitis C–Related Thrombocytopenia 

Used to increase platelet counts in patients undergoing antiviral therapy.

Treatment Benefits 

• Enables continuation of antiviral treatment
• Reduces bleeding complications

Who Can Take EnerplatTM (Eltrombopag) 50mg? 

This medicine should always be used under medical supervision.

Eligibility Criteria 

Patients may be prescribed Eltrombopag if they:

• Have chronic immune thrombocytopenia (ITP)
• Are diagnosed with aplastic anemia
• Have low platelet counts affecting treatment plans

Who Should Avoid Promacta (Eltrombopag) 50mg 

Eltrombopag should NOT be used by:

• Patients with severe liver impairment without monitoring
• Individuals with hypersensitivity to Eltrombopag
• Patients at high risk of thrombosis unless evaluated by a doctor

Promacta (Eltrombopag) 50mg Dosage and Administration 

Standard Dosage Guidelines 

Typical dosage recommendations include:

• EnerplatTM 50mg once daily
• Taken on an empty stomach
• Avoid taking with calcium-rich foods

Dosage Adjustments 

Doctors may adjust the dose depending on:

• Platelet count response
• Liver function
• Individual patient condition

Side Effects of Eltrombopag 50mg 

Like all medicines, Eltrombopag may cause side effects.

Common Side Effects 

• Headache
• Nausea
• Fatigue
• Increased liver enzymes

Serious Side Effects 

• Liver toxicity
• Blood clots
• Bone marrow fibrosis (rare)

Patients should report any unusual symptoms to their doctor immediately.

Storage:
Store below 25°C in a dry place, away from light and moisture. Keep out of reach of children.

Frequently Asked Questions (FAQs) 

1. What is EnerplatTM (Eltrombopag) 50mg used for? 

It is used to treat low platelet counts in conditions like ITP and aplastic anemia.

2. Is Eltrombopag a chemotherapy drug? 

No. It is a platelet-stimulating medicine, not chemotherapy.

3. How long does it take to work? 

Platelet counts may begin to improve within 1–2 weeks of treatment.

4. Can I take Eltrombopag with food? 

It should be taken on an empty stomach and not with calcium-rich foods.

5. Is EnerplatTM the same as Promacta? 

Yes. EnerplatTM contains Eltrombopag, the same active ingredient as Promacta.

6. Do I need a prescription for EnerplatTM 50mg? 

Yes. It is a prescription-only medicine.

7. Can pregnant women take Eltrombopag? 

It should only be used if clearly prescribed by a doctor after risk assessment.

Medical Disclaimer 

Disclaimer:
The information provided on this page is for educational purposes only and should not be considered medical advice. Eltrombopag is a prescription-only medicine and must be used under medical supervision. Always consult your healthcare provider before starting or stopping any medication.